Huadong Medicine Co., Ltd
000963
株式のランク
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
株価
$3.89
時価総額
$6.83B
変化（1日）
-2.22%
変化（1年）
-30.58%
国
CN
取引 Huadong Medicine Co., Ltd (000963)
カテゴリー
Healthcare
Huadong Medicine Co., Ltd（000963）の利益
Jun 2026 時点の利益 TTM: $604.11M
Huadong Medicine Co., Ltd の最新の財務報告によると、同社の現在の利益は $604.11M です。2024 年には $589.32M の利益を上げ、これは 2023 年の利益 $489.64M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Huadong Medicine Co., Ltd の利益の推移（2001 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $604.11M | 5.23% |
| 2025 | $574.08M | -2.59% |
| 2024 | $589.32M | 20.36% |
| 2023 | $489.64M | 11.43% |
| 2022 | $439.43M | -1.22% |
| 2021 | $444.87M | -15.85% |
| 2020 | $528.63M | 6.07% |
| 2019 | $498.37M | 19.34% |
| 2018 | $417.61M | 16.89% |
| 2017 | $357.26M | 31.78% |
| 2016 | $271.11M | 23.98% |
| 2015 | $218.66M | 15.48% |
| 2014 | $189.36M | 21.89% |
| 2013 | $155.35M | 23.01% |
| 2012 | $126.29M | 29.91% |
| 2011 | $97.22M | 29.50% |
| 2010 | $75.07M | -9.32% |
| 2009 | $82.78M | 100.08% |
| 2008 | $41.37M | -0.62% |
| 2007 | $41.63M | 84.19% |
| 2006 | $22.60M | 31.03% |
| 2005 | $17.25M | 50.58% |
| 2004 | $11.46M | 28.58% |
| 2003 | $8.91M | -7.36% |
| 2002 | $9.62M | -15.85% |
| 2001 | $11.43M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $1.72B | 185.31% |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 192.09% |
IN
|
